Paradigm Biopharmaceuticals | PAR - Ordinary Share Capital

Stock Price
0.27
Daily Change
-0.01 -1.82%
Monthly
-16.92%
Yearly
-53.04%
Q1 Forecast
0.27

Paradigm Biopharmaceuticals reported AUD253.24M in Ordinary Share Capital for its fiscal semester ending in December of 2024.





Ordinary Share Capital Change Date
Medical Developments International AUD 115.01M 9.28M Dec/2024
Neuren Pharmaceuticals AUD 165.27M 10.43M Dec/2024
Pacific Edge NZD 1.02B 210.22M Dec/2025
PYC Therapeutics AUD 230.58M 0 Dec/2024
Telix Pharmaceuticals AUD 338.78M 379K Dec/2025